Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

165
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
165
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

269
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
269
Response Surface Methodology01:16

Response Surface Methodology

242
Response Surface Methodology (RSM) is a collection of statistical and mathematical techniques used to develop, improve, and optimize processes. It is particularly valuable when many input variables or factors potentially influence a response variable.
The process of RSM involves several key steps:
242
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

182
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
182
Censoring Survival Data01:09

Censoring Survival Data

211
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ontological Analysis of Brain Proteostasis Highlights the Sex-Dependent Trajectory of ApoE Isoform-Specific Regulation.

bioRxiv : the preprint server for biology·2026
Same author

Somatic CRISPR editing of <i>Msh3</i> mitigates Huntington's disease pathology in mice.

bioRxiv : the preprint server for biology·2026
Same author

Genetic and epidemiological evidence linking respiratory and musculoskeletal diseases: shared risk factors and intervention windows.

Respiratory research·2026
Same author

Three-phase ScAlN-based PMUT-driven acoustic streaming micropump.

Microsystems & nanoengineering·2026
Same author

Psychological and functional assessment of Achilles tendon ruptures and their return to sports.

Foot (Edinburgh, Scotland)·2026
Same author

A mixed-methods systematic review of the attitudes, experiences, motivations and disclosure decisions among recipients of donor spermatozoa.

Reproductive biomedicine online·2026

Related Experiment Video

Updated: Sep 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study.

Tamir Sirkis1, Benjamin Jones2, Jack Bowden3

  • 1University of Exeter College of Medicine and Health, Exeter, UK. tamir@live.co.uk.

BMC Medical Research Methodology
|August 6, 2022
PubMed
Summary

Response-adaptive randomisation in COVID-19 trials could improve patient outcomes by directing more participants to effective treatments like dexamethasone. This method may reduce overall mortality and the number of patients needed for trials, while maintaining statistical integrity.

Keywords:
Adaptive trialCOVID-19CoronavirusPlatform trialRECOVERYREMAP-CAPResponse-adaptive randomizationSimulation

More Related Videos

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Related Experiment Videos

Last Updated: Sep 2, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats
08:06

Testing for Metacognitive Responding Using an Odor-based Delayed Match-to-Sample Test in Rats

Published on: June 18, 2018

7.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Area of Science:

  • Clinical Trials Methodology
  • Epidemiology
  • Biostatistics

Background:

  • The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial identified dexamethasone as a critical treatment for COVID-19 mortality.
  • The RECOVERY trial currently uses fixed randomisation, allocating patients equally to treatment arms.
  • Response-adaptive randomisation (RAR) is an alternative design that adjusts treatment allocation based on accumulating data.

Purpose of the Study:

  • To assess the impact of implementing response-adaptive randomisation (RAR) within the RECOVERY trial framework.
  • To evaluate if RAR could enhance treatment allocation efficiency and patient outcomes compared to fixed randomisation.
  • To explore the potential benefits of RAR in future clinical trial designs.

Main Methods:

  • Simulated clinical trial data mirroring RECOVERY trial patient demographics and outcomes (March-June 2020).
  • Compared two fixed randomisation (FR) strategies against two RAR strategies in simulated two-arm and four-arm trial settings.
  • Evaluated RAR's performance based on patient allocation, mortality rates, statistical power, bias, and type 1 error rates, including subgroup analyses.

Main Results:

  • All tested RAR strategies resulted in more patients receiving dexamethasone and lower overall mortality.
  • Subgroup-specific RAR further reduced mortality rates.
  • RAR demonstrated no significant bias in treatment effect estimates or inflation of type 1 error, though it reduced statistical power in some scenarios.

Conclusions:

  • Implementing RAR in the RECOVERY trial could have increased optimal treatment delivery and potentially accelerated the identification of effective therapies.
  • RAR may reduce the number of patients required to achieve desired statistical power, potentially saving lives during the trial.
  • RAR presents an ethically considerable design feature for future COVID-19 and other disease clinical trials, balancing immediate patient needs with future patient benefit.